Cargando…

Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models

BACKGROUND: Early revascularization of ischemic organs is key to improving outcomes, yet consequent reperfusion injury may be harmful. Reperfusion injury is largely attributed to excess mitochondrial production of reactive oxygen species (ROS). Sulfide inhibits mitochondria and reduces ROS productio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dyson, Alex, Dal-Pizzol, Felipe, Sabbatini, Giovanni, Lach, Anna B., Galfo, Federica, dos Santos Cardoso, Juliano, Pescador Mendonça, Bruna, Hargreaves, Iain, Bollen Pinto, Bernardo, Bromage, Daniel I., Martin, John F., Moore, Kevin P., Feelisch, Martin, Singer, Mervyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497958/ https://www.ncbi.nlm.nih.gov/pubmed/28678794 http://dx.doi.org/10.1371/journal.pmed.1002310

Ejemplares similares

Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke
por: Mendonça, Bruna Pescador, et al.
Publicado: (2020)

Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?
por: Li, Xiang, et al.
Publicado: (2020)

Ammonium tetrathiomolybdate treatment of copper‐associated hepatopathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2019)

Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway
por: Qi, Hao, et al.
Publicado: (2023)

Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells
por: Zhang, Mengling, et al.
Publicado: (2022)

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series
por: De Fabregues, Oriol, et al.
Publicado: (2020)

The copper chelator ammonium tetrathiomolybdate inhibits the progression of experimental endometriosis in TNFR1-deficient mice
por: Conforti, Rocío Ayelem, et al.
Publicado: (2023)

Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
por: Chisholm, Cristine L., et al.
Publicado: (2016)

0078. Establishing a detailed short-term rat model of partial ischaemia/reperfusion injury
por: Sabbatini, G, et al.
Publicado: (2014)

Effects of MGC-0109, a slow-release sulphide donor, on myocardial ischaemia/reperfusion injury
por: Dyson, A, et al.
Publicado: (2015)

How do you prefer your resuscitation solution? Do you want a little bit more salt?
por: Dal-Pizzol, Felipe, et al.
Publicado: (2012)

Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma
por: Ryumon, Shoji, et al.
Publicado: (2019)

Characterization of Brain–Heart Interactions in a Rodent Model of Sepsis
por: Pinto, Bernardo Bollen, et al.
Publicado: (2016)

The metabolic phenotype of rodent sepsis: cause for concern?
por: Zolfaghari, Parjam S, et al.
Publicado: (2013)

Inflammation biomarkers and delirium in critically ill patients
por: Ritter, Cristiane, et al.
Publicado: (2014)

Biomarkers for sepsis: more than just fever and leukocytosis—a narrative review
por: Barichello, Tatiana, et al.
Publicado: (2022)

Bis-choline tetrathiomolybdate prevents copper-induced blood–brain barrier damage
por: Borchard, Sabine, et al.
Publicado: (2021)

Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
por: Fang, Tiantian, et al.
Publicado: (2019)

Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate
por: Navrátilová, Jarmila, et al.
Publicado: (2017)

Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats
por: Omoto, Atsushi, et al.
Publicado: (2005)

Effects of statins on mitochondrial respiration and outcome during experimental sepsis
por: Morel, J, et al.
Publicado: (2012)

Tetrathiomolybdate Decreases the Expression of Alkaline Phosphatase in Dermal Papilla Cells by Increasing Mitochondrial ROS Production
por: Li, Fan, et al.
Publicado: (2023)

0592. Metabolic acidosis induced by haemorrhage and hydrochloric acid generates different cardiorespiratory responses
por: Sabbatini, G, et al.
Publicado: (2014)

Enhanced sulfidation xanthate flotation of malachite using ammonium ions as activator
por: Wu, Dandan, et al.
Publicado: (2017)

Uteroglobin-related protein 1 and severity of inhalation injury
por: Friedman, G, et al.
Publicado: (2015)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
por: Kim, Kyu Kwang, et al.
Publicado: (2012)

Bis‐choline Tetrathiomolybdate as Old Drug in a New Design for Wilson’s Disease: Good for Brain and Liver?
por: Stremmel, Wolfgang
Publicado: (2018)

Tetrathiomolybdate Treatment Attenuates Bleomycin-Induced Angiogenesis and Lung Pathology in a Sheep Model of Pulmonary Fibrosis
por: Derseh, Habtamu B., et al.
Publicado: (2021)

Analyzing the Therapeutic Efficacy of Bis-Choline-Tetrathiomolybdate in the Atp7b(−/−) Copper Overload Mouse Model
por: Kim, Philipp, et al.
Publicado: (2021)

0099. Nitrite reductase activity during sepsis
por: Simon, V, et al.
Publicado: (2014)

Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury
por: Wu, Dongdong, et al.
Publicado: (2015)

Hydrogen sulfide to the rescue in obstructive kidney injury
por: Kasinath, Balakuntalam S.
Publicado: (2014)

Sulfide catabolism ameliorates hypoxic brain injury
por: Marutani, Eizo, et al.
Publicado: (2021)

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
por: Doñate, F, et al.
Publicado: (2008)

Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
por: Kwang Kim, Kyu, et al.
Publicado: (2015)

Nitrosopersulfide (SSNO(−)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide()
por: Cortese-Krott, Miriam M., et al.
Publicado: (2014)

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
por: Kumar, Pawan, et al.
Publicado: (2010)

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
por: Kim, Kyu Kwang, et al.
Publicado: (2015)

Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer
por: Liu, Ying L., et al.
Publicado: (2021)

Evaluation of ATOX1 as a Potential Predictive Biomarker for Tetrathiomolybdate Treatment of Breast Cancer Patients with High Risk of Recurrence
por: Blockhuys, Stéphanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_en3arsasgj86sca7etguo79ear